GAP43 and early-onset autosomal dominant Alzheimer disease: CSF GAP-43 levels are increased in Alzheimer’s disease patients compared with other neurodegenerative disorders such as Parkinson’s disease and frontotemporal dementia and may be useful in the differential diagnosis of the disease.